Optimizing cystic fibrosis-related diabetes screening in adults using the oral glucose tolerance test (OGTT): a single center mixed methods study.

Background: Early diabetes detection can enhance metabolic outcomes, reducing future risks and complications. Effective diabetes screening remains crucial in the post cystic fibrosis (CF) modulator therapy era whereby treatment with Elexacaftor/Tezacaftor/Ivacaftor (ETI) will lead to an aging CF pop...

Descripción completa

Detalles Bibliográficos
Publicado en:JBI Evidence Implementation Vol. 24; no. 2; pp. 388 - 398
Autores principales: Matson, Angela G., Smith, Daniel, Loel, Felicity, Moore, Vanessa, Herd, Karen, Wagenaar, Monica, Kumar, Shanal
Formato: pictorial research tables/charts Journal Article
Publicado: Lippincott Williams & Wilkins Apr2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=193096436&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 193096436
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        26913321
        MO0F
      jtl: JBI Evidence Implementation
      issn: 26913321
      maglogo: N
    pubinfo:
      dt: Apr2026
      vid: 24
      iid: 2
      pid: 433
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        193096436
        193096436
        193096436
        10.1097/XEB.0000000000000531
        193096436
      ppf: 388
      ppct: 10
      formats:
      tig:
        atl: Optimizing cystic fibrosis-related diabetes screening in adults using the oral glucose tolerance test (OGTT): a single center mixed methods study.
      aug:
        au:
          Matson, Angela G.
          Smith, Daniel
          Loel, Felicity
          Moore, Vanessa
          Herd, Karen
          Wagenaar, Monica
          Kumar, Shanal
        affil: Nutrition and Dietetics Department, The Prince Charles Hospital, Brisbane, Qld, Australia
      sug:
        subj:
          Cystic Fibrosis Complications
          Diabetes Mellitus Diagnosis
          Health Screening Methods
          Glucose Tolerance Test Methods
          Implementation Science
          Diabetes Mellitus Etiology
          Health Services Research
          Human
          Male
          Female
          Adult
          Multimethod Studies
          Surveys
          Qualitative Studies
          Quantitative Studies
          Hospitals Australia
          Australia
          Early Diagnosis
          Professional Practice, Evidence-Based
          Behavioral Changes
          Critical Path
          Program Evaluation
          Health Personnel Education
          Patient Participation
          Multidisciplinary Care Team
          Guideline Adherence
          Decision Making, Clinical
          Retrospective Design
          Record Review
          Descriptive Statistics
          Fisher's Exact Test
          Semi-Structured Interview
          Funding Source
          Adult: 19-44 years
          Male
          Female
      ab: Background: Early diabetes detection can enhance metabolic outcomes, reducing future risks and complications. Effective diabetes screening remains crucial in the post cystic fibrosis (CF) modulator therapy era whereby treatment with Elexacaftor/Tezacaftor/Ivacaftor (ETI) will lead to an aging CF population. Therefore, adults living with CF will be at increased risk of metabolic complications, specifically diabetes. The oral glucose tolerance test (OGTT) remains a key validated diagnostic tool for diabetes in this population; however, uptake has been historically low. Aim: This study aimed to evaluate and address barriers to the uptake of OGTT screening for CF-related diabetes from a clinician and service perspective. Method: This single center mixed methods study comprised a survey, solution mapping workshops, and database-driven analytics, incorporating both qualitative and quantitative analyses. The study was conducted in a hospital in Brisbane, Australia from 2017 to 2023. We hybridized the Theoretical Domains Framework and the Capability, Opportunity, Motivation, and Behaviour (COM-B) change model to identify clinician- and service-level barriers to OGTT uptake. OGTT uptake was assessed at three time-points: T0 (2018–2019) Baseline/Pre-implementation, T1 (2020–2021) Post-implementation, and T2 (2022–2023) Post-implementation and ETI. Results: Three barriers to OGTT uptake were identified: (1) clinician capacity, (2) systematic processes, and (3) consumer engagement. Provider knowledge gaps on diabetes diagnostic criteria were addressed through education. A CF-related diabetes clinical pathway was developed and integrated into service procedures and clinical databases. Consumer engagement initiatives were implemented. In our cohort, OGTT screening significantly increased from 12.7% at T0 to 38.5% at T1 (p  < 0.001), stabilizing at 33.5% at T2 (p  < 0.001). Conclusions: OGTT screening significantly improved following the implementation of behavior-based solutions. Our findings indicate that addressing key barriers at a service level using a multifaceted interventional approach can change end-user perspectives and behavior. http://links.lww.com/IJEBH/A405
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N